HANSOH PHARMA Shares Surge Over 6% in Morning Trading Following Strong Annual Results

Deep News03-31

HANSOH PHARMA (03692) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 6.35%, trading at HK$35.18 with a turnover of HK$219 million.

The company recently announced its 2025 annual results. The group reported revenue of RMB 150.28 billion, a year-on-year increase of 22.57%. Profit attributable to owners of the parent company was RMB 55.55 billion, marking a growth of 27.07% compared to the previous year. A final dividend of HK 20.0 cents per share has been proposed.

It is noteworthy that for the year ended December 31, 2025, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue. This segment has become the core driver for the group's sustainable performance growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173691271?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 10:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173691271","market":"us","top_or_hot":-1,"title":"HANSOH PHARMA Shares Surge Over 6% in Morning Trading Following Strong Annual Results","media":"Deep News","content":"<p>HANSOH PHARMA (03692) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 6.35%, trading at HK$35.18 with a turnover of HK$219 million.</p>\n<p>The company recently announced its 2025 annual results. The group reported revenue of RMB 150.28 billion, a year-on-year increase of 22.57%. Profit attributable to owners of the parent company was RMB 55.55 billion, marking a growth of 27.07% compared to the previous year. A final dividend of HK 20.0 cents per share has been proposed.</p>\n<p>It is noteworthy that for the year ended December 31, 2025, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue. This segment has become the core driver for the group's sustainable performance growth.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HANSOH PHARMA Shares Surge Over 6% in Morning Trading Following Strong Annual Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHANSOH PHARMA Shares Surge Over 6% in Morning Trading Following Strong Annual Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-03-31 10:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HANSOH PHARMA (03692) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 6.35%, trading at HK$35.18 with a turnover of HK$219 million.</p>\n<p>The company recently announced its 2025 annual results. The group reported revenue of RMB 150.28 billion, a year-on-year increase of 22.57%. Profit attributable to owners of the parent company was RMB 55.55 billion, marking a growth of 27.07% compared to the previous year. A final dividend of HK 20.0 cents per share has been proposed.</p>\n<p>It is noteworthy that for the year ended December 31, 2025, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue. This segment has become the core driver for the group's sustainable performance growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1173691271","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173691271","pubTimestamp":1774925467,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"HANSOH PHARMA (03692) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 6.35%, trading at HK$35.18 with a turnover of HK$219 million. The company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药","BK1583":"高瓴概念","BK1589":"北水核心资产","BK1191":"制药"},"translate_title":"凭借强劲的年度业绩，豪森制药股价早盘飙升逾6%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"HANSOH PHARMA (03692) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 6.35%, trading at HK$35.18 with a turnover of HK$219 million.\nThe company recently announced its 2025 annual results. The group reported revenue of RMB 150.28 billion, a year-on-year increase of 22.57%. Profit attributable to owners of the parent company was RMB 55.55 billion, marking a growth of 27.07% compared to the previous year. A final dividend of HK 20.0 cents per share has been proposed.\nIt is noteworthy that for the year ended December 31, 2025, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue. This segment has become the core driver for the group's sustainable performance growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173691271","isCrawlerRequest":true}